Sign in

CIK 0000949858

  • Non-accelerated filer
  • Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Tickers
ACHV QUIT
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954343413
Phone
+1 425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC

Securities

  • ACHV Common stock Nasdaq
  • QUIT Common Shares Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4/A Open-market sale EVP, CMO sold 1,364 shares at $8.68 ($11,840)
  3. 4/A Open-market sale EVP, CMO sold 534 shares at $11.90 ($6,355)
  4. 4/A Open-market sale President and CEO sold 3,112 shares at $8.68 ($27,012)
  5. 4/A Open-market sale President and CEO sold 2,134 shares at $11.90 ($25,395)
  6. 4/A Open-market sale PAO sold 385 shares at an average $8.86 ($3,411)
  7. 4 Shares withheld for taxes PAO gave up 372 shares (to pay taxes)
  8. 4 Shares withheld for taxes President and CEO gave up 2,951 shares (to pay taxes)
  9. 4 Shares withheld for taxes EVP, CMO gave up 1,293 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  13. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  14. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 2,000 shares (option exercise)
  16. 4 Derivatives Options or other derivatives
  17. 4 Shares withheld for taxes EVP, CMO gave up 534 shares (to pay taxes)
  18. 4 Shares withheld for taxes President and CEO gave up 2,134 shares (to pay taxes)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Exercise or conversion Director acquired 513 shares (option exercise)

Page 15 of 24 · 465 filings